Detalles de la búsqueda
1.
Effectiveness of double-dose dolutegravir in people receiving rifampin-based tuberculosis treatment: an observational, cohort study of people with HIV from six countries.
Clin Infect Dis
; 2024 May 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38739755
2.
Safety and efficacy of inhaled interferon-ß1a (SNG001) in adults with mild-to-moderate COVID-19: a randomized, controlled, phase II trial.
EClinicalMedicine
; 65: 102250, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37855026
3.
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial.
J Int AIDS Soc
; 25(6): e25905, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36039892
4.
Resultados
1 -
4
de 4
1
Próxima >
>>